Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon

Minerva Cardioangiologica

Volumn 58, Issue 5, 2010, Pages 583-588

  Cremers, B ^a   Clever, Y ^a   Schaffner, S ^b   Speck, U ^c   Bohm M ^a   Scheller, B ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Invatec Technology Center   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Drug coated balloon; Paclitaxel; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; IOPROMIDE; PACLITAXEL; UREA;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BARE METAL STENT; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; CORONARY ARTERY RECANALIZATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CATHETERS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PACLITAXEL; STENTS; UREA;

EID: 79251485322     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1:263.
2. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J et al.; ISAR-DESIRE Study Investigators. Sirolimus eluting stent or paclitaxel eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-71.
3. Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S et al. ISAR-DESIRE 2 Investigators.Randomized trial of paclitaxel- versus sirolimus eluting stents for treatment of coronary restenosis in sirolimus eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010;55:2710-6.
4. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Treatment of in-stent restenosis with a paclitaxel coated balloon catheter. New Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
5. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Two year follow-up after treatment of coronary in-stent restenosis with the paclitaxel coated balloon catheter. Clin Res Cardiol 2008;97:773-81.
6. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C et al. Paclitaxel coated balloon catheter versus paclitaxel coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.
7. Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D et al. Dose-response to paclitaxel coated balloon catheters in the porcine coronary overstretch and stent implantation model. Submitted for publication, 2010.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et al.; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
9. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-4. (Pubitemid 39096008)
10. Biamino G. Drug eluting balloon applications beyond coronaries. EuroPCR, Paris, May 2010.
11. Schmidt A. IN.PACT BTK Registry Leipzig. LINC, Leipzig, January 2010.